http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1593385-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c116f9a96f308bfcdd99c80e1db8d036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f35c1a935a6193e6ebabbac1340a0aa5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-05 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ab5d614fc7516fb9c668fb8a37c5c3 |
| publicationDate | 2005-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1593385-A1 |
| titleOfInvention | Use of histones for the early diagnosis and/or preventive therapy of virus-infected living cells and a biochip for implementation of the diagnosis |
| abstract | The invention of a biologically active ingredient, especially for early diagnosisnand / or preventive therapy of virus-infected live cells, wherein itsnEffectively directed against the cell membranes of virus-infected cellsnwhich are modified in a characteristic manner after the virus attack, wherein thenActive ingredient includes at least one ingredient selected from anGroup of substances consisting of histones, covalently modified histones,nhistone-like polypeptides and biologically active sequences of histones andnhistone-like peptides.n n n The active ingredient is, for example, recombinant humannHistone H1 or at least one histone H1 subtype (H1.0, H1.1, H1.2, H1.3, H1.4,nH1.5, H1.t, H1.x) or its active section. The adequatenSize of biological activity for killing a virus-infected cell on hernmodified cell membrane by cooperativity with same orndifferent active ingredients be achievable with each othernform a biologically active complex with enhanced biological activity.n n n The invention also relates to a biochip for the diagnosis of virus-infected cells,nbeing a selected number of different biological agentsneach with a biological activity located on the biochip, for identificationnan individual profile of the disease, with the active ingredients selectednare from a group of substances consisting of histones, covalently modifiednHistones, histone-like polypeptides and biologically active sequences ofnHistones and histone-like peptides. |
| priorityDate | 2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.